Dr. Aamir Ahmad
My Social Links

Dr. Aamir Ahmad

Research Scientist
Wayne State University, USA


Highest Degree
Ph.D. in Biochemistry from Aligarh Muslim University, Aligarh, India

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Breast Cancer
62%
Cancer Stem Cells
90%
Chemoprevention
75%
Metastasis
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
28
Abstracts
0

Selected Publications

  1. Wang, Z., Y. Li, A. Ahmad, S. Banerjee and A.S. Azmi et al., 2011. Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells. J. Cell. Biochem., 112: 78-88.
    CrossRef  |  PubMed  |  Direct Link  |  
  2. Ahmad, A., Z. Wang, D. Kong, R. Ali and S. Ali et al., 2011. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways. Breast Cancer Res. Treat., 126: 15-25.
    CrossRef  |  PubMed  |  Direct Link  |  
  3. Wang, Z., Y. Li, D. Kong, A. Ahmad, S. Banerjee and F.H. Sarkar, 2010. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett., 292: 141-148.
    CrossRef  |  PubMed  |  Direct Link  |  
  4. Wang, Z., Y. Li, A. Ahmad, A.S. Azmi and S. Banerjee et al., 2010. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim. Biophys. Acta, Rev. Cancer, 1806: 258-267.
    CrossRef  |  PubMed  |  Direct Link  |  
  5. Wang, Z., A. Ahmad, Y. Li, S. Banerjee, D. Kong and F.H. Sarkar, 2010. Forkhead box M1 transcription factor: A novel target for cancer therapy. Cancer Treatment Rev., 36: 151-156.
    CrossRef  |  PubMed  |  Direct Link  |  
  6. Wang, Z., A. Ahmad, Y. Li, D. Kong, A.S. Azmi, S. Banerjee and F.H. Sarkar, 2010. Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochimica Biophys. Acta (BBA) Rev. Cancer, 1806: 122-130.
    CrossRef  |  PubMed  |  Direct Link  |  
  7. Wang, Z., A. Ahmad, S. Banerjee, A. Azmi, D. Kong, Y. Li and F.H. Sarkar, 2010. FoxM1 is a novel target of a natural agent in pancreatic cancer. Pharmaceutical Res., 27: 1159-1168.
    CrossRef  |  PubMed  |  Direct Link  |  
  8. Padhye, S., A. Ahmad, N. Oswal, P. Dandawate, R.A. Rub, J. Deshpande, K.V. Swamy and F.H. Sarkar, 2010. Fluorinated 2`-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities. Bioorg. Med. Chem. Lett., 20: 5818-5821.
    CrossRef  |  PubMed  |  Direct Link  |  
  9. Hadi, S.M., M.F. Ullah, A.S. Azmi, A. Ahmad, U. Shamim, H. Zubair and H.Y. Khan, 2010. Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer. Pharmaceutical Res., 27: 979-988.
    CrossRef  |  PubMed  |  Direct Link  |  
  10. Ali, S., A. Ahmad, S. Banerjee, S. Padhye and K. Dominiak et al., 2010. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res., 70: 3606-3617.
    CrossRef  |  PubMed  |  Direct Link  |  
  11. Ahmad, A., Z. Wang, D. Kong, S. Ali and Y. Li et al., 2010. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res. Treatment, 122: 337-346.
    CrossRef  |  PubMed  |  Direct Link  |  
  12. Ahmad, A., W.A. Sakr and K.M.W. Rahman, 2010. Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy. Current Drug Targets, 11: 652-666.
    CrossRef  |  PubMed  |  
  13. Wang, Z., Y. Li, D. Kong, S. Banerjee and A. Ahmad et al., 2009. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of notch signaling pathway. Cancer Res., 69: 2400-2407.
    CrossRef  |  PubMed  |  Direct Link  |  
  14. Wang, Z., A. Azmi, A. Ahmad, S. Banerjee, S. Wang, F. Sarkar and R. Mohammad, 2009. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: Involvement of Notch-1 signaling pathway. Cancer Res., 69: 2757-2765.
    CrossRef  |  PubMed  |  Direct Link  |  
  15. Rahman, K.M.W., S. Banerjee, S. Ali, A. Ahmad, Z. Wang, D. Kong and W.A. Sakr, 2009. 3, 3`-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Cancer Res., 69: 4468-4475.
    CrossRef  |  PubMed  |  Direct Link  |  
  16. Padhye, S., A. Ahmad, N. Oswal and F.H. Sarkar, 2009. Emerging role of garcinol, the antioxidant chalcone from Garcinia indica choisy and its synthetic analogs. J. Hematol. Oncol., 2: 1-13.
    CrossRef  |  PubMed  |  Direct Link  |  
  17. Nazeem, S., A.S. Azmi, S. Hanif, A. Ahmad, R.M. Mohammad, S.M. Hadi and K. S. Kumar, 2009. Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cells. Mutagenesis, 24: 413-418.
    CrossRef  |  PubMed  |  Direct Link  |  
  18. Kong, D., Y. Li, Z. Wang, S. Banerjee, A. Ahmad, H.R. Choi Kim and F.H. Sarkar, 2009. MiR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells, 27: 1712-1721.
    CrossRef  |  PubMed  |  Direct Link  |  
  19. Ahmad, A., S. Banerjee, Z. Wang, D. Kong, A.P.N. Majumdar and F.H. Sarkar, 2009. Aging and inflammation: Etiological culprits of cancer. Current Aging Sci., 2: 174-186.
    PubMed  |  Direct Link  |  
  20. Ahmad, A., D. Kong, Z. Wang, S.H. Sarkar, S. Banerjee and F.H. Sarkar, 2009. Down-regulation of uPA and uPAR by 3, 3`-Diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells. J. Cell. Biochem., 108: 916-925.
    CrossRef  |  PubMed  |  Direct Link  |  
  21. Ahmad, A., D. Kong, S.H. Sarkar, Z. Wang, S. Banerjee and F.H. Sarkar, 2009. Inactivation of uPA and its receptor uPAR by 3, 3`-Diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration. J. Cell. Biochem., 107: 516-527.
    CrossRef  |  PubMed  |  Direct Link  |  
  22. Padhye, S., S. Banerjee, A. Ahmad, R. Mohammad and F.H. Sarkar, 2008. From here to eternity-the secret of pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer Ther., 6: 495-510.
    PubMed  |  Direct Link  |  
  23. Khundmir, S.J., A. Ahmad, R. Bennett, E. Weinman and D. Steplock et al., 2008. Novel regulatory function for NHERF-1 in Npt2a transcription. Am. J. Physiol. Renal Physiol., 294: F840-F849.
    CrossRef  |  PubMed  |  Direct Link  |  
  24. Dass, K., A. Ahmad, A.S. Azmi, S.H. Sarkar and F.H. Sarkar, 2008. Evolving role of uPA/uPAR system in human cancers. Cancer Treatment Rev., 34: 122-136.
    CrossRef  |  PubMed  |  Direct Link  |  
  25. Azmi, A.S., A. Ahmad, S. Banerjee, V.M. Rangnekar, R.M. Mohammad and F.H. Sarkar, 2008. Chemoprevention of pancreatic cancer: Characterization of par-4 and its modulation by 3,3` Diindolylmethane (DIM). Pharmaceutical Res., 25: 2117-2124.
    CrossRef  |  PubMed  |  Direct Link  |  
  26. Ali, S., S. Banerjee, A. Ahmad, B.F. El-Rayes, P.A. Philip and F.H. Sarkar, 2008. Apoptosis-inducing effect of erlotinib is potentiated by 3, 3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Mol. Cancer Ther., 7: 1708-1719.
    CrossRef  |  PubMed  |  Direct Link  |  
  27. Khundmiri, S.J., E.J. Weinman, D. Steplock, J. Cole and A. Ahmad et al., 2005. Parathyroid hormone regulation of Na+,K+-ATPase requires the PDZ 1 domain of sodium hydrogen exchanger regulatory factor-1 in opossum kidney cells. J. Am. Society Nephrol., 16: 2598-2607.
    CrossRef  |  PubMed  |  Direct Link  |  
  28. Ahmad, A., S.F. Asad, S. Singh and S.M. Hadi, 2005. Prooxidant activity of resveratrol in the presence of copper ions: Mutagenicity in plasmid DNA. Toxicol. Lett., 159: 1-12.
    CrossRef  |  PubMed  |  Direct Link  |